Pharmacokinetics Study of Nimotuzumab in Patients With Solid Tumors
Clinical trial NCT02395068 · UNKNOWN
Trial details
- NCT number
- NCT02395068
- Sponsor
- Biotech Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2014-11-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.